nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—HTR2B—hypertension	0.159	0.469	CbGaD
Dihydroergotamine—HTR1B—hypertension	0.0955	0.281	CbGaD
Dihydroergotamine—ADRA2A—hypertension	0.0845	0.249	CbGaD
Dihydroergotamine—HTR1B—Pindolol—hypertension	0.0267	0.0649	CbGbCtD
Dihydroergotamine—HTR1B—Penbutolol—hypertension	0.0218	0.0529	CbGbCtD
Dihydroergotamine—HTR1A—Nebivolol—hypertension	0.0197	0.0478	CbGbCtD
Dihydroergotamine—ADRA2A—Methyldopa—hypertension	0.0188	0.0457	CbGbCtD
Dihydroergotamine—HTR1D—Prazosin—hypertension	0.018	0.0436	CbGbCtD
Dihydroergotamine—ADRA2A—Guanabenz—hypertension	0.0172	0.0418	CbGbCtD
Dihydroergotamine—HTR1A—Pindolol—hypertension	0.0167	0.0407	CbGbCtD
Dihydroergotamine—ADRA2A—Guanfacine—hypertension	0.016	0.0389	CbGbCtD
Dihydroergotamine—HTR1B—Propranolol—hypertension	0.0137	0.0332	CbGbCtD
Dihydroergotamine—HTR1A—Penbutolol—hypertension	0.0137	0.0331	CbGbCtD
Dihydroergotamine—ADRA2A—Fenoldopam—hypertension	0.0136	0.0331	CbGbCtD
Dihydroergotamine—ADRA2A—Doxazosin—hypertension	0.0126	0.0305	CbGbCtD
Dihydroergotamine—HTR1A—Prazosin—hypertension	0.0108	0.0262	CbGbCtD
Dihydroergotamine—ADRA2A—Prazosin—hypertension	0.0103	0.0251	CbGbCtD
Dihydroergotamine—ADRA2A—Carvedilol—hypertension	0.00891	0.0216	CbGbCtD
Dihydroergotamine—HTR1A—Propranolol—hypertension	0.00857	0.0208	CbGbCtD
Dihydroergotamine—ADRA2A—Clonidine—hypertension	0.00782	0.019	CbGbCtD
Dihydroergotamine—ABCB1—Nadolol—hypertension	0.00665	0.0161	CbGbCtD
Dihydroergotamine—ABCB1—Acebutolol—hypertension	0.00608	0.0148	CbGbCtD
Dihydroergotamine—ABCB1—Metoprolol—hypertension	0.00565	0.0137	CbGbCtD
Dihydroergotamine—ABCB1—Candesartan—hypertension	0.00565	0.0137	CbGbCtD
Dihydroergotamine—ABCB1—Terazosin—hypertension	0.00532	0.0129	CbGbCtD
Dihydroergotamine—CYP3A4—Guanethidine—hypertension	0.00526	0.0128	CbGbCtD
Dihydroergotamine—ABCB1—Reserpine—hypertension	0.00504	0.0122	CbGbCtD
Dihydroergotamine—ABCB1—Perindopril—hypertension	0.00461	0.0112	CbGbCtD
Dihydroergotamine—ABCB1—Nisoldipine—hypertension	0.00444	0.0108	CbGbCtD
Dihydroergotamine—ABCB1—Doxazosin—hypertension	0.00444	0.0108	CbGbCtD
Dihydroergotamine—ABCB1—Diltiazem—hypertension	0.00428	0.0104	CbGbCtD
Dihydroergotamine—ABCB1—Telmisartan—hypertension	0.00403	0.00978	CbGbCtD
Dihydroergotamine—CYP3A4—Hydralazine—hypertension	0.00398	0.00967	CbGbCtD
Dihydroergotamine—ABCB1—Bepridil—hypertension	0.00382	0.00927	CbGbCtD
Dihydroergotamine—ABCB1—Enalapril—hypertension	0.00382	0.00927	CbGbCtD
Dihydroergotamine—ABCB1—Lisinopril—hypertension	0.00382	0.00927	CbGbCtD
Dihydroergotamine—ABCB1—Prazosin—hypertension	0.00364	0.00884	CbGbCtD
Dihydroergotamine—ABCB1—Amlodipine—hypertension	0.00343	0.00832	CbGbCtD
Dihydroergotamine—CYP3A4—Guanfacine—hypertension	0.00339	0.00822	CbGbCtD
Dihydroergotamine—ABCB1—Spironolactone—hypertension	0.00336	0.00816	CbGbCtD
Dihydroergotamine—ABCB1—Felodipine—hypertension	0.0033	0.00802	CbGbCtD
Dihydroergotamine—ABCB1—Timolol—hypertension	0.00325	0.00788	CbGbCtD
Dihydroergotamine—ABCB1—Nifedipine—hypertension	0.00319	0.00776	CbGbCtD
Dihydroergotamine—ABCB1—Nicardipine—hypertension	0.00314	0.00763	CbGbCtD
Dihydroergotamine—ABCB1—Carvedilol—hypertension	0.00314	0.00763	CbGbCtD
Dihydroergotamine—CYP3A4—Isradipine—hypertension	0.00302	0.00733	CbGbCtD
Dihydroergotamine—ABCB1—Propranolol—hypertension	0.00289	0.00703	CbGbCtD
Dihydroergotamine—ABCB1—Captopril—hypertension	0.00286	0.00694	CbGbCtD
Dihydroergotamine—ABCB1—Clonidine—hypertension	0.00276	0.0067	CbGbCtD
Dihydroergotamine—CYP3A4—Nisoldipine—hypertension	0.00266	0.00645	CbGbCtD
Dihydroergotamine—CYP3A4—Indapamide—hypertension	0.00266	0.00645	CbGbCtD
Dihydroergotamine—CYP3A4—Eplerenone—hypertension	0.00257	0.00623	CbGbCtD
Dihydroergotamine—CYP3A4—Diltiazem—hypertension	0.00257	0.00623	CbGbCtD
Dihydroergotamine—ABCB1—Atorvastatin—hypertension	0.00246	0.00597	CbGbCtD
Dihydroergotamine—CYP3A4—Enalapril—hypertension	0.00229	0.00555	CbGbCtD
Dihydroergotamine—ABCB1—Losartan—hypertension	0.00225	0.00546	CbGbCtD
Dihydroergotamine—CYP3A4—Irbesartan—hypertension	0.00209	0.00508	CbGbCtD
Dihydroergotamine—CYP3A4—Amlodipine—hypertension	0.00205	0.00498	CbGbCtD
Dihydroergotamine—ABCB1—Verapamil—hypertension	0.00199	0.00482	CbGbCtD
Dihydroergotamine—CYP3A4—Felodipine—hypertension	0.00198	0.0048	CbGbCtD
Dihydroergotamine—CYP3A4—Nifedipine—hypertension	0.00191	0.00465	CbGbCtD
Dihydroergotamine—CYP3A4—Nicardipine—hypertension	0.00188	0.00457	CbGbCtD
Dihydroergotamine—CYP3A4—Carvedilol—hypertension	0.00188	0.00457	CbGbCtD
Dihydroergotamine—CYP3A4—Propranolol—hypertension	0.00173	0.00421	CbGbCtD
Dihydroergotamine—CYP3A4—Clonidine—hypertension	0.00165	0.00402	CbGbCtD
Dihydroergotamine—CYP3A4—Atorvastatin—hypertension	0.00147	0.00358	CbGbCtD
Dihydroergotamine—CYP3A4—Losartan—hypertension	0.00135	0.00327	CbGbCtD
Dihydroergotamine—CYP3A4—Verapamil—hypertension	0.00119	0.00289	CbGbCtD
Dihydroergotamine—HTR1B—artery—hypertension	0.000824	0.0731	CbGeAlD
Dihydroergotamine—HTR1D—artery—hypertension	0.000798	0.0708	CbGeAlD
Dihydroergotamine—HTR1B—blood vessel—hypertension	0.000642	0.057	CbGeAlD
Dihydroergotamine—HTR1D—blood vessel—hypertension	0.000622	0.0552	CbGeAlD
Dihydroergotamine—CYP3A4—urine—hypertension	0.000527	0.0468	CbGeAlD
Dihydroergotamine—HTR1B—brainstem—hypertension	0.000351	0.0311	CbGeAlD
Dihydroergotamine—HTR1D—brainstem—hypertension	0.00034	0.0302	CbGeAlD
Dihydroergotamine—Ergotamine—ADRA2B—hypertension	0.000317	0.0918	CrCbGaD
Dihydroergotamine—Bromocriptine—ADRA2B—hypertension	0.000305	0.0885	CrCbGaD
Dihydroergotamine—HTR6—central nervous system—hypertension	0.000294	0.0261	CbGeAlD
Dihydroergotamine—HTR1B—cardiovascular system—hypertension	0.000286	0.0254	CbGeAlD
Dihydroergotamine—HTR1A—brainstem—hypertension	0.000283	0.0251	CbGeAlD
Dihydroergotamine—HTR2B—adrenal cortex—hypertension	0.000283	0.0251	CbGeAlD
Dihydroergotamine—Ergotamine—SLC6A2—hypertension	0.000278	0.0806	CrCbGaD
Dihydroergotamine—HTR1D—cardiovascular system—hypertension	0.000277	0.0246	CbGeAlD
Dihydroergotamine—HTR2B—heart—hypertension	0.000273	0.0243	CbGeAlD
Dihydroergotamine—HTR1D—kidney—hypertension	0.000271	0.0241	CbGeAlD
Dihydroergotamine—HTR2B—smooth muscle tissue—hypertension	0.000271	0.0241	CbGeAlD
Dihydroergotamine—Ergoloid mesylate—DRD2—hypertension	0.00027	0.0781	CrCbGaD
Dihydroergotamine—HTR2B—decidua—hypertension	0.000266	0.0236	CbGeAlD
Dihydroergotamine—Ergotamine—HTR2B—hypertension	0.000261	0.0757	CrCbGaD
Dihydroergotamine—HTR2B—cardiovascular system—hypertension	0.000258	0.0229	CbGeAlD
Dihydroergotamine—Bromocriptine—HTR2B—hypertension	0.000252	0.073	CrCbGaD
Dihydroergotamine—HTR2B—cortex of kidney—hypertension	0.000246	0.0218	CbGeAlD
Dihydroergotamine—HTR1A—cardiovascular system—hypertension	0.000231	0.0205	CbGeAlD
Dihydroergotamine—HTR2B—adrenal gland—hypertension	0.000204	0.0181	CbGeAlD
Dihydroergotamine—ABCB1—blood vessel—hypertension	0.000202	0.018	CbGeAlD
Dihydroergotamine—HTR1B—endocrine gland—hypertension	0.000196	0.0174	CbGeAlD
Dihydroergotamine—Ergotamine—ADRA1A—hypertension	0.000196	0.0568	CrCbGaD
Dihydroergotamine—Bromocriptine—ADRA1A—hypertension	0.000189	0.0548	CrCbGaD
Dihydroergotamine—HTR1A—adrenal gland—hypertension	0.000183	0.0162	CbGeAlD
Dihydroergotamine—HTR1B—central nervous system—hypertension	0.000177	0.0157	CbGeAlD
Dihydroergotamine—ADRA2A—heart—hypertension	0.000172	0.0152	CbGeAlD
Dihydroergotamine—HTR1D—central nervous system—hypertension	0.000171	0.0152	CbGeAlD
Dihydroergotamine—ADRA2A—decidua—hypertension	0.000167	0.0148	CbGeAlD
Dihydroergotamine—HTR2B—central nervous system—hypertension	0.000159	0.0141	CbGeAlD
Dihydroergotamine—HTR1A—endocrine gland—hypertension	0.000159	0.0141	CbGeAlD
Dihydroergotamine—Ergotamine—HTR1B—hypertension	0.000157	0.0454	CrCbGaD
Dihydroergotamine—Bromocriptine—HTR7—hypertension	0.000156	0.0452	CrCbGaD
Dihydroergotamine—ADRA2A—cortex of kidney—hypertension	0.000154	0.0137	CbGeAlD
Dihydroergotamine—Bromocriptine—HTR1B—hypertension	0.000151	0.0438	CrCbGaD
Dihydroergotamine—ADRA2A—cardiac atrium—hypertension	0.000147	0.013	CbGeAlD
Dihydroergotamine—Bromocriptine—DRD3—hypertension	0.000147	0.0425	CrCbGaD
Dihydroergotamine—HTR1A—central nervous system—hypertension	0.000143	0.0127	CbGeAlD
Dihydroergotamine—Ergotamine—ADRA2A—hypertension	0.000139	0.0402	CrCbGaD
Dihydroergotamine—ADRA2A—medulla oblongata—hypertension	0.000138	0.0123	CbGeAlD
Dihydroergotamine—Bromocriptine—ADRA2A—hypertension	0.000134	0.0388	CrCbGaD
Dihydroergotamine—Bromocriptine—ADRB1—hypertension	0.000134	0.0387	CrCbGaD
Dihydroergotamine—ADRA2A—adrenal gland—hypertension	0.000128	0.0114	CbGeAlD
Dihydroergotamine—CYP3A4—kidney—hypertension	0.000125	0.0111	CbGeAlD
Dihydroergotamine—ADRA2A—endocrine gland—hypertension	0.000111	0.00986	CbGeAlD
Dihydroergotamine—Ergotamine—DRD2—hypertension	0.000105	0.0305	CrCbGaD
Dihydroergotamine—Bromocriptine—DRD2—hypertension	0.000101	0.0294	CrCbGaD
Dihydroergotamine—ABCB1—nephron tubule—hypertension	0.0001	0.00892	CbGeAlD
Dihydroergotamine—ADRA2A—central nervous system—hypertension	0.0001	0.00889	CbGeAlD
Dihydroergotamine—ABCB1—adrenal cortex—hypertension	9.89e-05	0.00878	CbGeAlD
Dihydroergotamine—ABCB1—heart—hypertension	9.56e-05	0.00849	CbGeAlD
Dihydroergotamine—ABCB1—decidua—hypertension	9.3e-05	0.00826	CbGeAlD
Dihydroergotamine—ABCB1—cardiovascular system—hypertension	9.03e-05	0.00801	CbGeAlD
Dihydroergotamine—ABCB1—kidney—hypertension	8.83e-05	0.00784	CbGeAlD
Dihydroergotamine—CYP3A4—endocrine gland—hypertension	8.75e-05	0.00776	CbGeAlD
Dihydroergotamine—ABCB1—cortex of kidney—hypertension	8.6e-05	0.00763	CbGeAlD
Dihydroergotamine—Ergotamine—HTR2A—hypertension	8.13e-05	0.0236	CrCbGaD
Dihydroergotamine—CYP3A4—central nervous system—hypertension	7.88e-05	0.00699	CbGeAlD
Dihydroergotamine—Bromocriptine—HTR2A—hypertension	7.84e-05	0.0227	CrCbGaD
Dihydroergotamine—ABCB1—medulla oblongata—hypertension	7.71e-05	0.00684	CbGeAlD
Dihydroergotamine—ABCB1—adrenal gland—hypertension	7.14e-05	0.00634	CbGeAlD
Dihydroergotamine—ABCB1—endocrine gland—hypertension	6.19e-05	0.00549	CbGeAlD
Dihydroergotamine—ABCB1—central nervous system—hypertension	5.58e-05	0.00495	CbGeAlD
Dihydroergotamine—Diarrhoea—Valsartan—hypertension	2.24e-05	0.000148	CcSEcCtD
Dihydroergotamine—Asthenia—Clonidine—hypertension	2.24e-05	0.000148	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Betaxolol—hypertension	2.24e-05	0.000147	CcSEcCtD
Dihydroergotamine—Confusional state—Timolol—hypertension	2.24e-05	0.000147	CcSEcCtD
Dihydroergotamine—Vomiting—Verapamil—hypertension	2.24e-05	0.000147	CcSEcCtD
Dihydroergotamine—Urticaria—Irbesartan—hypertension	2.24e-05	0.000147	CcSEcCtD
Dihydroergotamine—Shock—Ramipril—hypertension	2.24e-05	0.000147	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Enalapril—hypertension	2.24e-05	0.000147	CcSEcCtD
Dihydroergotamine—Body temperature increased—Perindopril—hypertension	2.24e-05	0.000147	CcSEcCtD
Dihydroergotamine—Abdominal pain—Perindopril—hypertension	2.24e-05	0.000147	CcSEcCtD
Dihydroergotamine—Palpitations—Lisinopril—hypertension	2.23e-05	0.000147	CcSEcCtD
Dihydroergotamine—Diarrhoea—Olmesartan—hypertension	2.23e-05	0.000147	CcSEcCtD
Dihydroergotamine—Headache—Eplerenone—hypertension	2.23e-05	0.000147	CcSEcCtD
Dihydroergotamine—Rash—Nifedipine—hypertension	2.23e-05	0.000147	CcSEcCtD
Dihydroergotamine—Dermatitis—Nifedipine—hypertension	2.23e-05	0.000147	CcSEcCtD
Dihydroergotamine—Body temperature increased—Irbesartan—hypertension	2.23e-05	0.000147	CcSEcCtD
Dihydroergotamine—Abdominal pain—Irbesartan—hypertension	2.23e-05	0.000147	CcSEcCtD
Dihydroergotamine—Oedema—Timolol—hypertension	2.22e-05	0.000146	CcSEcCtD
Dihydroergotamine—Rash—Verapamil—hypertension	2.22e-05	0.000146	CcSEcCtD
Dihydroergotamine—Urticaria—Hydrochlorothiazide—hypertension	2.22e-05	0.000146	CcSEcCtD
Dihydroergotamine—Tachycardia—Ramipril—hypertension	2.22e-05	0.000146	CcSEcCtD
Dihydroergotamine—Dermatitis—Verapamil—hypertension	2.22e-05	0.000146	CcSEcCtD
Dihydroergotamine—Headache—Nifedipine—hypertension	2.22e-05	0.000146	CcSEcCtD
Dihydroergotamine—Pruritus—Clonidine—hypertension	2.21e-05	0.000145	CcSEcCtD
Dihydroergotamine—Body temperature increased—Hydrochlorothiazide—hypertension	2.21e-05	0.000145	CcSEcCtD
Dihydroergotamine—Abdominal pain—Hydrochlorothiazide—hypertension	2.21e-05	0.000145	CcSEcCtD
Dihydroergotamine—Headache—Verapamil—hypertension	2.21e-05	0.000145	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Telmisartan—hypertension	2.21e-05	0.000145	CcSEcCtD
Dihydroergotamine—Nausea—Indapamide—hypertension	2.2e-05	0.000145	CcSEcCtD
Dihydroergotamine—Nausea—Diltiazem—hypertension	2.2e-05	0.000145	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Ramipril—hypertension	2.2e-05	0.000145	CcSEcCtD
Dihydroergotamine—Asthenia—Trandolapril—hypertension	2.19e-05	0.000144	CcSEcCtD
Dihydroergotamine—Shock—Timolol—hypertension	2.19e-05	0.000144	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Losartan—hypertension	2.19e-05	0.000144	CcSEcCtD
Dihydroergotamine—Urticaria—Furosemide—hypertension	2.18e-05	0.000144	CcSEcCtD
Dihydroergotamine—Nausea—Carvedilol—hypertension	2.18e-05	0.000143	CcSEcCtD
Dihydroergotamine—Asthenia—Enalapril—hypertension	2.18e-05	0.000143	CcSEcCtD
Dihydroergotamine—Abdominal pain—Furosemide—hypertension	2.17e-05	0.000143	CcSEcCtD
Dihydroergotamine—Body temperature increased—Furosemide—hypertension	2.17e-05	0.000143	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Losartan—hypertension	2.17e-05	0.000143	CcSEcCtD
Dihydroergotamine—Dizziness—Valsartan—hypertension	2.17e-05	0.000143	CcSEcCtD
Dihydroergotamine—Anorexia—Ramipril—hypertension	2.17e-05	0.000143	CcSEcCtD
Dihydroergotamine—Urticaria—Betaxolol—hypertension	2.16e-05	0.000142	CcSEcCtD
Dihydroergotamine—Dizziness—Olmesartan—hypertension	2.16e-05	0.000142	CcSEcCtD
Dihydroergotamine—Pruritus—Trandolapril—hypertension	2.16e-05	0.000142	CcSEcCtD
Dihydroergotamine—Nausea—Doxazosin—hypertension	2.16e-05	0.000142	CcSEcCtD
Dihydroergotamine—Myalgia—Lisinopril—hypertension	2.15e-05	0.000142	CcSEcCtD
Dihydroergotamine—Arthralgia—Lisinopril—hypertension	2.15e-05	0.000142	CcSEcCtD
Dihydroergotamine—Body temperature increased—Betaxolol—hypertension	2.15e-05	0.000141	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Timolol—hypertension	2.15e-05	0.000141	CcSEcCtD
Dihydroergotamine—Asthenia—Telmisartan—hypertension	2.15e-05	0.000141	CcSEcCtD
Dihydroergotamine—Pruritus—Enalapril—hypertension	2.15e-05	0.000141	CcSEcCtD
Dihydroergotamine—Anxiety—Lisinopril—hypertension	2.15e-05	0.000141	CcSEcCtD
Dihydroergotamine—Diarrhoea—Clonidine—hypertension	2.14e-05	0.000141	CcSEcCtD
Dihydroergotamine—Nausea—Fosinopril—hypertension	2.13e-05	0.00014	CcSEcCtD
Dihydroergotamine—Discomfort—Lisinopril—hypertension	2.13e-05	0.00014	CcSEcCtD
Dihydroergotamine—Hypotension—Ramipril—hypertension	2.13e-05	0.00014	CcSEcCtD
Dihydroergotamine—Anorexia—Timolol—hypertension	2.12e-05	0.000139	CcSEcCtD
Dihydroergotamine—Pruritus—Telmisartan—hypertension	2.12e-05	0.000139	CcSEcCtD
Dihydroergotamine—Nausea—Eplerenone—hypertension	2.12e-05	0.000139	CcSEcCtD
Dihydroergotamine—Urticaria—Losartan—hypertension	2.11e-05	0.000139	CcSEcCtD
Dihydroergotamine—Dry mouth—Lisinopril—hypertension	2.11e-05	0.000138	CcSEcCtD
Dihydroergotamine—Nausea—Nifedipine—hypertension	2.1e-05	0.000138	CcSEcCtD
Dihydroergotamine—Abdominal pain—Losartan—hypertension	2.1e-05	0.000138	CcSEcCtD
Dihydroergotamine—Body temperature increased—Losartan—hypertension	2.1e-05	0.000138	CcSEcCtD
Dihydroergotamine—Nausea—Verapamil—hypertension	2.09e-05	0.000138	CcSEcCtD
Dihydroergotamine—Asthenia—Captopril—hypertension	2.09e-05	0.000137	CcSEcCtD
Dihydroergotamine—Diarrhoea—Trandolapril—hypertension	2.09e-05	0.000137	CcSEcCtD
Dihydroergotamine—Vomiting—Valsartan—hypertension	2.09e-05	0.000137	CcSEcCtD
Dihydroergotamine—Confusional state—Lisinopril—hypertension	2.08e-05	0.000137	CcSEcCtD
Dihydroergotamine—Diarrhoea—Enalapril—hypertension	2.08e-05	0.000137	CcSEcCtD
Dihydroergotamine—Hypotension—Timolol—hypertension	2.08e-05	0.000137	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Irbesartan—hypertension	2.08e-05	0.000137	CcSEcCtD
Dihydroergotamine—Vomiting—Olmesartan—hypertension	2.08e-05	0.000136	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Ramipril—hypertension	2.07e-05	0.000136	CcSEcCtD
Dihydroergotamine—Rash—Valsartan—hypertension	2.07e-05	0.000136	CcSEcCtD
Dihydroergotamine—Dizziness—Clonidine—hypertension	2.07e-05	0.000136	CcSEcCtD
Dihydroergotamine—Dermatitis—Valsartan—hypertension	2.07e-05	0.000136	CcSEcCtD
Dihydroergotamine—Oedema—Lisinopril—hypertension	2.06e-05	0.000136	CcSEcCtD
Dihydroergotamine—Pruritus—Captopril—hypertension	2.06e-05	0.000136	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Hydrochlorothiazide—hypertension	2.06e-05	0.000135	CcSEcCtD
Dihydroergotamine—Rash—Olmesartan—hypertension	2.06e-05	0.000135	CcSEcCtD
Dihydroergotamine—Insomnia—Ramipril—hypertension	2.06e-05	0.000135	CcSEcCtD
Dihydroergotamine—Dermatitis—Olmesartan—hypertension	2.06e-05	0.000135	CcSEcCtD
Dihydroergotamine—Headache—Valsartan—hypertension	2.06e-05	0.000135	CcSEcCtD
Dihydroergotamine—Diarrhoea—Telmisartan—hypertension	2.05e-05	0.000135	CcSEcCtD
Dihydroergotamine—Headache—Olmesartan—hypertension	2.05e-05	0.000134	CcSEcCtD
Dihydroergotamine—Paraesthesia—Ramipril—hypertension	2.04e-05	0.000134	CcSEcCtD
Dihydroergotamine—Shock—Lisinopril—hypertension	2.03e-05	0.000133	CcSEcCtD
Dihydroergotamine—Asthenia—Perindopril—hypertension	2.03e-05	0.000133	CcSEcCtD
Dihydroergotamine—Dyspnoea—Ramipril—hypertension	2.03e-05	0.000133	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Timolol—hypertension	2.03e-05	0.000133	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Furosemide—hypertension	2.03e-05	0.000133	CcSEcCtD
Dihydroergotamine—Asthenia—Irbesartan—hypertension	2.02e-05	0.000133	CcSEcCtD
Dihydroergotamine—Somnolence—Ramipril—hypertension	2.02e-05	0.000133	CcSEcCtD
Dihydroergotamine—Dizziness—Trandolapril—hypertension	2.02e-05	0.000133	CcSEcCtD
Dihydroergotamine—Tachycardia—Lisinopril—hypertension	2.01e-05	0.000132	CcSEcCtD
Dihydroergotamine—Insomnia—Timolol—hypertension	2.01e-05	0.000132	CcSEcCtD
Dihydroergotamine—Dizziness—Enalapril—hypertension	2.01e-05	0.000132	CcSEcCtD
Dihydroergotamine—Asthenia—Hydrochlorothiazide—hypertension	2.01e-05	0.000132	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Betaxolol—hypertension	2.01e-05	0.000132	CcSEcCtD
Dihydroergotamine—Dyspepsia—Ramipril—hypertension	2e-05	0.000132	CcSEcCtD
Dihydroergotamine—Pruritus—Perindopril—hypertension	2e-05	0.000132	CcSEcCtD
Dihydroergotamine—Paraesthesia—Timolol—hypertension	2e-05	0.000131	CcSEcCtD
Dihydroergotamine—Pruritus—Irbesartan—hypertension	1.99e-05	0.000131	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Lisinopril—hypertension	1.99e-05	0.000131	CcSEcCtD
Dihydroergotamine—Diarrhoea—Captopril—hypertension	1.99e-05	0.000131	CcSEcCtD
Dihydroergotamine—Vomiting—Clonidine—hypertension	1.99e-05	0.000131	CcSEcCtD
Dihydroergotamine—Dyspnoea—Timolol—hypertension	1.98e-05	0.00013	CcSEcCtD
Dihydroergotamine—Dizziness—Telmisartan—hypertension	1.98e-05	0.00013	CcSEcCtD
Dihydroergotamine—Pruritus—Hydrochlorothiazide—hypertension	1.98e-05	0.00013	CcSEcCtD
Dihydroergotamine—Decreased appetite—Ramipril—hypertension	1.98e-05	0.00013	CcSEcCtD
Dihydroergotamine—Somnolence—Timolol—hypertension	1.98e-05	0.00013	CcSEcCtD
Dihydroergotamine—Asthenia—Furosemide—hypertension	1.97e-05	0.00013	CcSEcCtD
Dihydroergotamine—Rash—Clonidine—hypertension	1.97e-05	0.00013	CcSEcCtD
Dihydroergotamine—Dermatitis—Clonidine—hypertension	1.97e-05	0.00013	CcSEcCtD
Dihydroergotamine—Anorexia—Lisinopril—hypertension	1.97e-05	0.000129	CcSEcCtD
Dihydroergotamine—Fatigue—Ramipril—hypertension	1.96e-05	0.000129	CcSEcCtD
Dihydroergotamine—Headache—Clonidine—hypertension	1.96e-05	0.000129	CcSEcCtD
Dihydroergotamine—Dyspepsia—Timolol—hypertension	1.96e-05	0.000129	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Losartan—hypertension	1.95e-05	0.000129	CcSEcCtD
Dihydroergotamine—Asthenia—Betaxolol—hypertension	1.95e-05	0.000128	CcSEcCtD
Dihydroergotamine—Nausea—Valsartan—hypertension	1.95e-05	0.000128	CcSEcCtD
Dihydroergotamine—Pruritus—Furosemide—hypertension	1.95e-05	0.000128	CcSEcCtD
Dihydroergotamine—Nausea—Olmesartan—hypertension	1.94e-05	0.000127	CcSEcCtD
Dihydroergotamine—Vomiting—Trandolapril—hypertension	1.94e-05	0.000127	CcSEcCtD
Dihydroergotamine—Diarrhoea—Perindopril—hypertension	1.94e-05	0.000127	CcSEcCtD
Dihydroergotamine—Decreased appetite—Timolol—hypertension	1.93e-05	0.000127	CcSEcCtD
Dihydroergotamine—Vomiting—Enalapril—hypertension	1.93e-05	0.000127	CcSEcCtD
Dihydroergotamine—Diarrhoea—Irbesartan—hypertension	1.93e-05	0.000127	CcSEcCtD
Dihydroergotamine—Hypotension—Lisinopril—hypertension	1.93e-05	0.000127	CcSEcCtD
Dihydroergotamine—Dizziness—Captopril—hypertension	1.93e-05	0.000127	CcSEcCtD
Dihydroergotamine—Pruritus—Betaxolol—hypertension	1.93e-05	0.000127	CcSEcCtD
Dihydroergotamine—Rash—Trandolapril—hypertension	1.92e-05	0.000126	CcSEcCtD
Dihydroergotamine—Dermatitis—Trandolapril—hypertension	1.92e-05	0.000126	CcSEcCtD
Dihydroergotamine—Fatigue—Timolol—hypertension	1.92e-05	0.000126	CcSEcCtD
Dihydroergotamine—Rash—Enalapril—hypertension	1.92e-05	0.000126	CcSEcCtD
Dihydroergotamine—Dermatitis—Enalapril—hypertension	1.91e-05	0.000126	CcSEcCtD
Dihydroergotamine—Diarrhoea—Hydrochlorothiazide—hypertension	1.91e-05	0.000126	CcSEcCtD
Dihydroergotamine—Headache—Trandolapril—hypertension	1.91e-05	0.000126	CcSEcCtD
Dihydroergotamine—Vomiting—Telmisartan—hypertension	1.91e-05	0.000125	CcSEcCtD
Dihydroergotamine—Asthenia—Losartan—hypertension	1.9e-05	0.000125	CcSEcCtD
Dihydroergotamine—Headache—Enalapril—hypertension	1.9e-05	0.000125	CcSEcCtD
Dihydroergotamine—Pain—Timolol—hypertension	1.9e-05	0.000125	CcSEcCtD
Dihydroergotamine—Rash—Telmisartan—hypertension	1.89e-05	0.000124	CcSEcCtD
Dihydroergotamine—Dermatitis—Telmisartan—hypertension	1.89e-05	0.000124	CcSEcCtD
Dihydroergotamine—Diarrhoea—Furosemide—hypertension	1.88e-05	0.000124	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Lisinopril—hypertension	1.88e-05	0.000124	CcSEcCtD
Dihydroergotamine—Pruritus—Losartan—hypertension	1.88e-05	0.000123	CcSEcCtD
Dihydroergotamine—Headache—Telmisartan—hypertension	1.88e-05	0.000123	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Ramipril—hypertension	1.87e-05	0.000123	CcSEcCtD
Dihydroergotamine—Dizziness—Perindopril—hypertension	1.87e-05	0.000123	CcSEcCtD
Dihydroergotamine—Insomnia—Lisinopril—hypertension	1.87e-05	0.000123	CcSEcCtD
Dihydroergotamine—Dizziness—Irbesartan—hypertension	1.86e-05	0.000123	CcSEcCtD
Dihydroergotamine—Diarrhoea—Betaxolol—hypertension	1.86e-05	0.000122	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Ramipril—hypertension	1.86e-05	0.000122	CcSEcCtD
Dihydroergotamine—Nausea—Clonidine—hypertension	1.86e-05	0.000122	CcSEcCtD
Dihydroergotamine—Paraesthesia—Lisinopril—hypertension	1.85e-05	0.000122	CcSEcCtD
Dihydroergotamine—Vomiting—Captopril—hypertension	1.85e-05	0.000122	CcSEcCtD
Dihydroergotamine—Dizziness—Hydrochlorothiazide—hypertension	1.85e-05	0.000122	CcSEcCtD
Dihydroergotamine—Dyspnoea—Lisinopril—hypertension	1.84e-05	0.000121	CcSEcCtD
Dihydroergotamine—Rash—Captopril—hypertension	1.84e-05	0.000121	CcSEcCtD
Dihydroergotamine—Dermatitis—Captopril—hypertension	1.84e-05	0.000121	CcSEcCtD
Dihydroergotamine—Somnolence—Lisinopril—hypertension	1.83e-05	0.000121	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Timolol—hypertension	1.83e-05	0.00012	CcSEcCtD
Dihydroergotamine—Headache—Captopril—hypertension	1.83e-05	0.00012	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Timolol—hypertension	1.82e-05	0.00012	CcSEcCtD
Dihydroergotamine—Dizziness—Furosemide—hypertension	1.82e-05	0.00012	CcSEcCtD
Dihydroergotamine—Dyspepsia—Lisinopril—hypertension	1.82e-05	0.000119	CcSEcCtD
Dihydroergotamine—Diarrhoea—Losartan—hypertension	1.82e-05	0.000119	CcSEcCtD
Dihydroergotamine—Nausea—Trandolapril—hypertension	1.81e-05	0.000119	CcSEcCtD
Dihydroergotamine—Urticaria—Ramipril—hypertension	1.81e-05	0.000119	CcSEcCtD
Dihydroergotamine—Nausea—Enalapril—hypertension	1.8e-05	0.000119	CcSEcCtD
Dihydroergotamine—Dizziness—Betaxolol—hypertension	1.8e-05	0.000118	CcSEcCtD
Dihydroergotamine—Vomiting—Perindopril—hypertension	1.8e-05	0.000118	CcSEcCtD
Dihydroergotamine—Abdominal pain—Ramipril—hypertension	1.8e-05	0.000118	CcSEcCtD
Dihydroergotamine—Body temperature increased—Ramipril—hypertension	1.8e-05	0.000118	CcSEcCtD
Dihydroergotamine—Decreased appetite—Lisinopril—hypertension	1.79e-05	0.000118	CcSEcCtD
Dihydroergotamine—Vomiting—Irbesartan—hypertension	1.79e-05	0.000118	CcSEcCtD
Dihydroergotamine—Rash—Perindopril—hypertension	1.78e-05	0.000117	CcSEcCtD
Dihydroergotamine—Dermatitis—Perindopril—hypertension	1.78e-05	0.000117	CcSEcCtD
Dihydroergotamine—Nausea—Telmisartan—hypertension	1.78e-05	0.000117	CcSEcCtD
Dihydroergotamine—Fatigue—Lisinopril—hypertension	1.78e-05	0.000117	CcSEcCtD
Dihydroergotamine—Vomiting—Hydrochlorothiazide—hypertension	1.78e-05	0.000117	CcSEcCtD
Dihydroergotamine—Rash—Irbesartan—hypertension	1.78e-05	0.000117	CcSEcCtD
Dihydroergotamine—Dermatitis—Irbesartan—hypertension	1.78e-05	0.000117	CcSEcCtD
Dihydroergotamine—Headache—Perindopril—hypertension	1.77e-05	0.000117	CcSEcCtD
Dihydroergotamine—Urticaria—Timolol—hypertension	1.77e-05	0.000116	CcSEcCtD
Dihydroergotamine—Headache—Irbesartan—hypertension	1.77e-05	0.000116	CcSEcCtD
Dihydroergotamine—Pain—Lisinopril—hypertension	1.76e-05	0.000116	CcSEcCtD
Dihydroergotamine—Rash—Hydrochlorothiazide—hypertension	1.76e-05	0.000116	CcSEcCtD
Dihydroergotamine—Dermatitis—Hydrochlorothiazide—hypertension	1.76e-05	0.000116	CcSEcCtD
Dihydroergotamine—Abdominal pain—Timolol—hypertension	1.76e-05	0.000116	CcSEcCtD
Dihydroergotamine—Body temperature increased—Timolol—hypertension	1.76e-05	0.000116	CcSEcCtD
Dihydroergotamine—Dizziness—Losartan—hypertension	1.75e-05	0.000115	CcSEcCtD
Dihydroergotamine—Headache—Hydrochlorothiazide—hypertension	1.75e-05	0.000115	CcSEcCtD
Dihydroergotamine—Vomiting—Furosemide—hypertension	1.75e-05	0.000115	CcSEcCtD
Dihydroergotamine—Rash—Furosemide—hypertension	1.73e-05	0.000114	CcSEcCtD
Dihydroergotamine—Dermatitis—Furosemide—hypertension	1.73e-05	0.000114	CcSEcCtD
Dihydroergotamine—Vomiting—Betaxolol—hypertension	1.73e-05	0.000114	CcSEcCtD
Dihydroergotamine—Nausea—Captopril—hypertension	1.73e-05	0.000114	CcSEcCtD
Dihydroergotamine—Headache—Furosemide—hypertension	1.72e-05	0.000113	CcSEcCtD
Dihydroergotamine—Rash—Betaxolol—hypertension	1.72e-05	0.000113	CcSEcCtD
Dihydroergotamine—Dermatitis—Betaxolol—hypertension	1.72e-05	0.000113	CcSEcCtD
Dihydroergotamine—Headache—Betaxolol—hypertension	1.71e-05	0.000112	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Lisinopril—hypertension	1.7e-05	0.000112	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Lisinopril—hypertension	1.69e-05	0.000111	CcSEcCtD
Dihydroergotamine—Vomiting—Losartan—hypertension	1.69e-05	0.000111	CcSEcCtD
Dihydroergotamine—Nausea—Perindopril—hypertension	1.68e-05	0.00011	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Ramipril—hypertension	1.68e-05	0.00011	CcSEcCtD
Dihydroergotamine—Nausea—Irbesartan—hypertension	1.67e-05	0.00011	CcSEcCtD
Dihydroergotamine—Rash—Losartan—hypertension	1.67e-05	0.00011	CcSEcCtD
Dihydroergotamine—Dermatitis—Losartan—hypertension	1.67e-05	0.00011	CcSEcCtD
Dihydroergotamine—Headache—Losartan—hypertension	1.66e-05	0.000109	CcSEcCtD
Dihydroergotamine—Nausea—Hydrochlorothiazide—hypertension	1.66e-05	0.000109	CcSEcCtD
Dihydroergotamine—Urticaria—Lisinopril—hypertension	1.64e-05	0.000108	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Timolol—hypertension	1.64e-05	0.000108	CcSEcCtD
Dihydroergotamine—Nausea—Furosemide—hypertension	1.63e-05	0.000107	CcSEcCtD
Dihydroergotamine—Asthenia—Ramipril—hypertension	1.63e-05	0.000107	CcSEcCtD
Dihydroergotamine—Abdominal pain—Lisinopril—hypertension	1.63e-05	0.000107	CcSEcCtD
Dihydroergotamine—Body temperature increased—Lisinopril—hypertension	1.63e-05	0.000107	CcSEcCtD
Dihydroergotamine—Nausea—Betaxolol—hypertension	1.62e-05	0.000106	CcSEcCtD
Dihydroergotamine—Pruritus—Ramipril—hypertension	1.61e-05	0.000106	CcSEcCtD
Dihydroergotamine—Asthenia—Timolol—hypertension	1.6e-05	0.000105	CcSEcCtD
Dihydroergotamine—Nausea—Losartan—hypertension	1.58e-05	0.000104	CcSEcCtD
Dihydroergotamine—Pruritus—Timolol—hypertension	1.57e-05	0.000103	CcSEcCtD
Dihydroergotamine—Diarrhoea—Ramipril—hypertension	1.56e-05	0.000102	CcSEcCtD
Dihydroergotamine—Diarrhoea—Timolol—hypertension	1.52e-05	0.0001	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Lisinopril—hypertension	1.52e-05	9.99e-05	CcSEcCtD
Dihydroergotamine—Dizziness—Ramipril—hypertension	1.5e-05	9.89e-05	CcSEcCtD
Dihydroergotamine—Asthenia—Lisinopril—hypertension	1.48e-05	9.73e-05	CcSEcCtD
Dihydroergotamine—Dizziness—Timolol—hypertension	1.47e-05	9.67e-05	CcSEcCtD
Dihydroergotamine—Pruritus—Lisinopril—hypertension	1.46e-05	9.6e-05	CcSEcCtD
Dihydroergotamine—Vomiting—Ramipril—hypertension	1.45e-05	9.51e-05	CcSEcCtD
Dihydroergotamine—Rash—Ramipril—hypertension	1.43e-05	9.43e-05	CcSEcCtD
Dihydroergotamine—Dermatitis—Ramipril—hypertension	1.43e-05	9.42e-05	CcSEcCtD
Dihydroergotamine—Headache—Ramipril—hypertension	1.43e-05	9.37e-05	CcSEcCtD
Dihydroergotamine—Vomiting—Timolol—hypertension	1.41e-05	9.3e-05	CcSEcCtD
Dihydroergotamine—Diarrhoea—Lisinopril—hypertension	1.41e-05	9.28e-05	CcSEcCtD
Dihydroergotamine—Rash—Timolol—hypertension	1.4e-05	9.22e-05	CcSEcCtD
Dihydroergotamine—Dermatitis—Timolol—hypertension	1.4e-05	9.21e-05	CcSEcCtD
Dihydroergotamine—Headache—Timolol—hypertension	1.39e-05	9.16e-05	CcSEcCtD
Dihydroergotamine—Dizziness—Lisinopril—hypertension	1.36e-05	8.97e-05	CcSEcCtD
Dihydroergotamine—Nausea—Ramipril—hypertension	1.35e-05	8.88e-05	CcSEcCtD
Dihydroergotamine—Nausea—Timolol—hypertension	1.32e-05	8.69e-05	CcSEcCtD
Dihydroergotamine—Vomiting—Lisinopril—hypertension	1.31e-05	8.62e-05	CcSEcCtD
Dihydroergotamine—Rash—Lisinopril—hypertension	1.3e-05	8.55e-05	CcSEcCtD
Dihydroergotamine—Dermatitis—Lisinopril—hypertension	1.3e-05	8.55e-05	CcSEcCtD
Dihydroergotamine—Headache—Lisinopril—hypertension	1.29e-05	8.5e-05	CcSEcCtD
Dihydroergotamine—Nausea—Lisinopril—hypertension	1.23e-05	8.06e-05	CcSEcCtD
Dihydroergotamine—ADRA2A—Signaling Pathways—ITGB3—hypertension	1.86e-06	2.27e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PRKCA—hypertension	1.86e-06	2.27e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—YWHAZ—hypertension	1.84e-06	2.25e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CXCL8—hypertension	1.84e-06	2.25e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CXCL8—hypertension	1.83e-06	2.23e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NGF—hypertension	1.82e-06	2.22e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—SPP1—hypertension	1.82e-06	2.22e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CXCL8—hypertension	1.82e-06	2.21e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ALOX5—hypertension	1.8e-06	2.2e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GLP1R—hypertension	1.8e-06	2.2e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CXCL8—hypertension	1.79e-06	2.18e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—RELA—hypertension	1.79e-06	2.18e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—AKT1—hypertension	1.78e-06	2.17e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PRKCD—hypertension	1.77e-06	2.16e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCR5—hypertension	1.77e-06	2.16e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—COMT—hypertension	1.77e-06	2.16e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—AKT1—hypertension	1.77e-06	2.16e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—POMC—hypertension	1.76e-06	2.15e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—INS—hypertension	1.75e-06	2.14e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—IL6—hypertension	1.75e-06	2.14e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—MTOR—hypertension	1.75e-06	2.14e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—GNB3—hypertension	1.75e-06	2.13e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PPARGC1A—hypertension	1.75e-06	2.13e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—HMOX1—hypertension	1.74e-06	2.12e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—IL6—hypertension	1.74e-06	2.12e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR2A—hypertension	1.74e-06	2.12e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—C3—hypertension	1.73e-06	2.11e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—AKT1—hypertension	1.73e-06	2.11e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCL2—hypertension	1.73e-06	2.1e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CAT—hypertension	1.72e-06	2.09e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—IL6—hypertension	1.7e-06	2.08e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—GNAS—hypertension	1.7e-06	2.08e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IGF1—hypertension	1.7e-06	2.07e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—AKT2—hypertension	1.7e-06	2.07e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—EGFR—hypertension	1.69e-06	2.06e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PDGFB—hypertension	1.69e-06	2.06e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CXCL8—hypertension	1.68e-06	2.05e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PPARG—hypertension	1.68e-06	2.05e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—FGFR1—hypertension	1.68e-06	2.05e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—APOB—hypertension	1.67e-06	2.03e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—MMP9—hypertension	1.67e-06	2.03e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CDKN1A—hypertension	1.66e-06	2.03e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—POMC—hypertension	1.66e-06	2.02e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—PTEN—hypertension	1.66e-06	2.02e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—MMP9—hypertension	1.66e-06	2.02e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HIF1A—hypertension	1.65e-06	2.02e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ALDH2—hypertension	1.65e-06	2.01e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—INS—hypertension	1.65e-06	2.01e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CDKN1A—hypertension	1.65e-06	2.01e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—AGT—hypertension	1.65e-06	2.01e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—PTEN—hypertension	1.65e-06	2.01e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—AKT1—hypertension	1.64e-06	2e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—AKT1—hypertension	1.63e-06	1.98e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—GSTM1—hypertension	1.62e-06	1.98e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—MAPK8—hypertension	1.62e-06	1.98e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—MMP9—hypertension	1.62e-06	1.98e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CALM1—hypertension	1.62e-06	1.98e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—AKT1—hypertension	1.62e-06	1.97e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CDKN1A—hypertension	1.61e-06	1.97e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—LEP—hypertension	1.61e-06	1.97e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—APOE—hypertension	1.61e-06	1.97e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—SERPINE1—hypertension	1.61e-06	1.97e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—PTEN—hypertension	1.61e-06	1.96e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—MAPK8—hypertension	1.61e-06	1.96e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—HBA1—hypertension	1.61e-06	1.96e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—AKT1—hypertension	1.61e-06	1.96e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—IL6—hypertension	1.6e-06	1.95e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CAV1—hypertension	1.6e-06	1.95e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CYP11A1—hypertension	1.6e-06	1.95e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—APOA1—hypertension	1.6e-06	1.95e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—LPL—hypertension	1.59e-06	1.94e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—KDR—hypertension	1.58e-06	1.93e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—EP300—hypertension	1.58e-06	1.93e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—MAPK8—hypertension	1.58e-06	1.92e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—AKT1—hypertension	1.57e-06	1.92e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—SLC9A1—hypertension	1.57e-06	1.91e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GSTT1—hypertension	1.57e-06	1.91e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—EP300—hypertension	1.57e-06	1.91e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—FGF2—hypertension	1.56e-06	1.9e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ADCY5—hypertension	1.56e-06	1.9e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—RHOA—hypertension	1.55e-06	1.9e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—GPX1—hypertension	1.55e-06	1.89e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GCLC—hypertension	1.55e-06	1.89e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CETP—hypertension	1.55e-06	1.89e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NOS3—hypertension	1.54e-06	1.88e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PIK3R1—hypertension	1.54e-06	1.88e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PRKCA—hypertension	1.54e-06	1.88e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CYP1A1—hypertension	1.54e-06	1.88e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—SRC—hypertension	1.54e-06	1.87e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—EP300—hypertension	1.54e-06	1.87e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—SRC—hypertension	1.53e-06	1.86e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PRKCB—hypertension	1.52e-06	1.86e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—FN1—hypertension	1.52e-06	1.86e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—F2—hypertension	1.52e-06	1.86e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—MMP9—hypertension	1.52e-06	1.86e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CDKN1A—hypertension	1.52e-06	1.85e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—PTEN—hypertension	1.51e-06	1.85e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CD36—hypertension	1.51e-06	1.85e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—ALB—hypertension	1.51e-06	1.84e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—VEGFA—hypertension	1.5e-06	1.83e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—SRC—hypertension	1.49e-06	1.82e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NOTCH1—hypertension	1.49e-06	1.82e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—VEGFA—hypertension	1.49e-06	1.81e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CYP17A1—hypertension	1.49e-06	1.81e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—MAPK8—hypertension	1.48e-06	1.81e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—AKT1—hypertension	1.48e-06	1.8e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PTGS1—hypertension	1.47e-06	1.79e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ENO1—hypertension	1.47e-06	1.79e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—VEGFA—hypertension	1.46e-06	1.77e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—RELA—hypertension	1.45e-06	1.77e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—NOS3—hypertension	1.45e-06	1.76e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PIK3R1—hypertension	1.45e-06	1.76e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—EP300—hypertension	1.44e-06	1.76e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—MTHFR—hypertension	1.43e-06	1.75e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—MTOR—hypertension	1.42e-06	1.73e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CTGF—hypertension	1.42e-06	1.73e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PPARA—hypertension	1.41e-06	1.72e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—SRC—hypertension	1.4e-06	1.71e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—HMGCR—hypertension	1.4e-06	1.71e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GOT2—hypertension	1.4e-06	1.71e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—POMC—hypertension	1.39e-06	1.69e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—INS—hypertension	1.38e-06	1.68e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—MYC—hypertension	1.38e-06	1.68e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TGFB1—hypertension	1.37e-06	1.68e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ADRA2A—hypertension	1.37e-06	1.67e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—MYC—hypertension	1.37e-06	1.67e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—VEGFA—hypertension	1.37e-06	1.67e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CXCL8—hypertension	1.37e-06	1.66e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TGFB1—hypertension	1.36e-06	1.66e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—AGT—hypertension	1.36e-06	1.66e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCL2—hypertension	1.36e-06	1.65e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—EGFR—hypertension	1.35e-06	1.64e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CALM1—hypertension	1.34e-06	1.63e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—MYC—hypertension	1.34e-06	1.63e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—EGFR—hypertension	1.34e-06	1.63e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TGFB1—hypertension	1.34e-06	1.63e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—APOE—hypertension	1.34e-06	1.63e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IGF1—hypertension	1.33e-06	1.63e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—AKT2—hypertension	1.33e-06	1.63e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—EGFR—hypertension	1.33e-06	1.62e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PTGS2—hypertension	1.32e-06	1.61e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CAV1—hypertension	1.32e-06	1.61e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—APOA1—hypertension	1.32e-06	1.61e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—AKT1—hypertension	1.32e-06	1.61e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—EGFR—hypertension	1.31e-06	1.6e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—IL6—hypertension	1.3e-06	1.58e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—TH—hypertension	1.29e-06	1.57e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CALM2—hypertension	1.28e-06	1.56e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—SERPINE1—hypertension	1.27e-06	1.54e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—MYC—hypertension	1.26e-06	1.53e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TGFB1—hypertension	1.25e-06	1.53e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GCG—hypertension	1.25e-06	1.52e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—SLC2A4—hypertension	1.25e-06	1.52e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—MMP9—hypertension	1.23e-06	1.51e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—EGFR—hypertension	1.23e-06	1.5e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CDKN1A—hypertension	1.23e-06	1.5e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PTEN—hypertension	1.23e-06	1.5e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—FGF2—hypertension	1.23e-06	1.5e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—RHOA—hypertension	1.22e-06	1.49e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GOT1—hypertension	1.21e-06	1.48e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NOS3—hypertension	1.21e-06	1.47e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PIK3R1—hypertension	1.21e-06	1.47e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—MAPK8—hypertension	1.2e-06	1.46e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—AKT1—hypertension	1.2e-06	1.46e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CYP19A1—hypertension	1.18e-06	1.43e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—STK11—hypertension	1.18e-06	1.43e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—EP300—hypertension	1.17e-06	1.43e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PPARG—hypertension	1.16e-06	1.42e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PTEN—hypertension	1.15e-06	1.41e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—POMC—hypertension	1.15e-06	1.4e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—INS—hypertension	1.14e-06	1.39e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—RELA—hypertension	1.14e-06	1.39e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—SRC—hypertension	1.14e-06	1.39e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TP53—hypertension	1.13e-06	1.38e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TP53—hypertension	1.12e-06	1.37e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—MTOR—hypertension	1.12e-06	1.36e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—VEGFA—hypertension	1.11e-06	1.35e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—EP300—hypertension	1.1e-06	1.34e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TP53—hypertension	1.1e-06	1.34e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—COMT—hypertension	1.09e-06	1.33e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GNB3—hypertension	1.08e-06	1.31e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PPARGC1A—hypertension	1.08e-06	1.31e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—HMOX1—hypertension	1.07e-06	1.31e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CXCL8—hypertension	1.07e-06	1.31e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CAT—hypertension	1.06e-06	1.29e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GNAS—hypertension	1.05e-06	1.28e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ALB—hypertension	1.05e-06	1.27e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—AKT1—hypertension	1.04e-06	1.26e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—IL6—hypertension	1.04e-06	1.26e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TP53—hypertension	1.03e-06	1.26e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—IL6—hypertension	1.03e-06	1.25e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—APOB—hypertension	1.03e-06	1.25e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—IL6—hypertension	1.02e-06	1.24e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—MYC—hypertension	1.02e-06	1.24e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TGFB1—hypertension	1.02e-06	1.24e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IL6—hypertension	1.01e-06	1.23e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—NOS3—hypertension	1e-06	1.22e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PIK3R1—hypertension	1e-06	1.22e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GSTM1—hypertension	1e-06	1.22e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—EGFR—hypertension	9.98e-07	1.22e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—LPL—hypertension	9.81e-07	1.2e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—MMP9—hypertension	9.7e-07	1.18e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CDKN1A—hypertension	9.67e-07	1.18e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PTEN—hypertension	9.65e-07	1.18e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ADCY5—hypertension	9.61e-07	1.17e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—GPX1—hypertension	9.57e-07	1.17e-05	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—AKT1—hypertension	9.56e-07	1.17e-05	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—AKT1—hypertension	9.48e-07	1.16e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PRKCA—hypertension	9.48e-07	1.16e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CYP1A1—hypertension	9.48e-07	1.16e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IL6—hypertension	9.46e-07	1.15e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—MAPK8—hypertension	9.44e-07	1.15e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—AKT1—hypertension	9.41e-07	1.15e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CD36—hypertension	9.32e-07	1.14e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—AKT1—hypertension	9.29e-07	1.13e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—EP300—hypertension	9.2e-07	1.12e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PTGS2—hypertension	9.15e-07	1.12e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—SRC—hypertension	8.95e-07	1.09e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—MTHFR—hypertension	8.84e-07	1.08e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—AKT1—hypertension	8.72e-07	1.06e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—VEGFA—hypertension	8.71e-07	1.06e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PPARA—hypertension	8.67e-07	1.06e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—AGT—hypertension	8.4e-07	1.02e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TP53—hypertension	8.38e-07	1.02e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CALM1—hypertension	8.25e-07	1.01e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—APOE—hypertension	8.23e-07	1e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CAV1—hypertension	8.15e-07	9.94e-06	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—APOA1—hypertension	8.13e-07	9.91e-06	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—MYC—hypertension	8.02e-07	9.77e-06	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TGFB1—hypertension	8e-07	9.75e-06	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PTEN—hypertension	7.98e-07	9.73e-06	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—EGFR—hypertension	7.84e-07	9.56e-06	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IL6—hypertension	7.67e-07	9.35e-06	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—EP300—hypertension	7.61e-07	9.28e-06	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PPARG—hypertension	7.16e-07	8.73e-06	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—AKT1—hypertension	7.07e-07	8.62e-06	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—POMC—hypertension	7.07e-07	8.61e-06	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—INS—hypertension	7.03e-07	8.57e-06	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—AKT1—hypertension	6.65e-07	8.11e-06	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TP53—hypertension	6.58e-07	8.03e-06	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ALB—hypertension	6.44e-07	7.85e-06	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—NOS3—hypertension	6.16e-07	7.51e-06	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PIK3R1—hypertension	6.16e-07	7.51e-06	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL6—hypertension	6.03e-07	7.35e-06	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PTGS2—hypertension	5.64e-07	6.87e-06	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—AKT1—hypertension	5.56e-07	6.78e-06	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PTEN—hypertension	4.92e-07	5.99e-06	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—EP300—hypertension	4.69e-07	5.71e-06	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—AKT1—hypertension	4.6e-07	5.61e-06	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—AKT1—hypertension	2.83e-07	3.45e-06	CbGpPWpGaD
